Company Comparison
Alnylam vs 10x Genomics
Side-by-side comparison of two portfolio companies — sector, funding stage, investors, valuation, and more.
| Metric | Alnylam | 10x Genomics |
|---|---|---|
| Sector | Biotech | Biotech |
| Headquarters | Cambridge, Massachusetts | — |
| Founded | 2002 | — |
| Status | Active | Active |
| Last Funding Stage | — | — |
| Total Funding | — | — |
| Valuation | — | — |
What They Build
Alnylam
Alnylam Pharmaceuticals, Inc. is an American biopharmaceutical company focused on the discovery, development and commercialization of RNA interference (RNAi) therapeutics for genetically defined diseases.
10x Genomics
10x Genomics, Inc. is an American biotechnology company that designs and manufactures sequencing technologies for use in scientific research, with a focus on product development for single-cell and spatial omics.
Key Investors
Shared Investors
1 firm has invested in both Alnylam and 10x Genomics.
Sector Overlap
Both Alnylam and 10x Genomics operate in Biotech.
Browse all Biotech companies →